US2016082275A1PendingUtilityA1

Adaptive medium voltage therapy for cardiac arrhythmias

52
Assignee: GALVANI LTDPriority: Jul 2, 2009Filed: Sep 28, 2015Published: Mar 24, 2016
Est. expiryJul 2, 2029(~3 yrs left)· nominal 20-yr term from priority
A61N 1/3968A61N 1/3925A61N 1/3993A61N 1/36564A61N 1/3621A61N 1/362A61N 1/3605A61N 1/3904A61N 1/39044A61N 1/3956
52
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Aspects of the invention are directed to advanced monitoring and control of medium voltage therapy (MVT) in implantable and external devices. Apparatus and methods are disclosed that facilitate dynamic adjustment of MVT parameter values in response to new and changing circumstances such as the patient's condition before, during, and after administration of MVT. Administration of MVT is automatically and dynamically adjusted to achieve specific treatment or life-support objectives, such as prolongation of the body's ability to endure and respond to MVT, specifically addressing the type of arrhythmia or other pathologic state of the patient with targeted treatment, a tiered-intensity MVT treatment strategy, and supporting patients in non life-critical conditions where the heart may nevertheless benefit from a certain level of assistance.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . A device for administrating medium voltage therapy substantially as shown and described herein, and its equivalents. 
     
     
         2 . A method for administrating medium voltage therapy substantially as shown and described herein, and its equivalents.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.